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Although transmission of human hepatitis B virus (HBV) variants to nonhuman primates is well
documented, it remains to be elucidated whether nonhuman primate HBV is transmissible to
humans. The prevalence and transmission routes of gibbon HBV were analysed in 101 captive
gibbons in Thailand. Approximately 40% of these animals showed at least one marker of HBV
infection; 19 animals were chronic HBV carriers, characterized by elevated levels of alanine amino
transferase and the presence of HBV DNA. Some of the chronic animals were found to be anti-HBc
(HBV core antigen) negative (4 of 19), while precore promoter point mutations (nt 1762 or 1764)
were determined in four animals by RFLP analysis. Phylogenetic tree analysis of the complete
surface gene sequences revealed that gibbon viruses clustered separately from hepadnaviruses of
other hosts. Evidence for horizontal and vertical transmission in captive gibbons was obtained. HBV
DNAwas also detected in the saliva of HBV carrier gibbons. Although some of the animal caretakers
at the Krabok Koo Wildlife Breeding Centre were found to be chronic HBV carriers, genotype and
sequence analysis did not reveal any evidence for zoonotic disease transmission.
INTRODUCTION
Hepatitis B virus (HBV), a small double-shelled virus that
contains a partially double-stranded DNA genome of
approximately 3200 bases (White & Fenner, 1994), is
found in several species, including woodchuck, ground
squirrel, a range of bird species, such as duck, goose and grey
heron (Mason et al., 1980; Marion et al., 1980; Summers
et al., 1978), and nonhuman primates like chimpanzee
(Pan troglodytes), woolly monkey (Lagothrix lagothrica),
orang-utan (Pongo pygmaeus) and gorilla (Gorilla gorilla)
(Grethe et al., 2000; Lanford et al., 1998; Vaudin et al., 1988;
Warren et al., 1999). HBV was also isolated from a gibbon,
infected in the wild and housed at the CDC for 2 years
(Mimms et al., 1993). Phylogenetic analysis of the complete
genome revealed that gibbon HBV represents a unique
group when compared to HBV genotypes described previ-
ously. Remarkably, a 33 bp deletion after the start codon of
preS1, the most divergent part of the genome, was observed
(Norder et al., 1996). Nonrecognition of an anti-preS1
monoclonal antibody at aa 27–35 to gibbon virus particles
confirmed that the gibbon HBV surface protein conforma-
tion is different from that of human HBV (Mimms et al.,
1993).
Phylogenetically, HBV isolated from gibbons and chimp-
anzees share an early lineage, indicating that these viruses
were indigenous to their respective hosts (Norder et al.,
1996). On the other hand, infection of chimpanzees with
human and gibbon HBV can be accomplished (Gallagher
et al., 1991). Experimental transmission of human HBV to
gibbons by exposure to human saliva containing HBV has
been reported also (Bancroft et al., 1977; Scott et al., 1980).
Replication of human HBV in the respective animals
supported the close relation of these hosts and may indicate
natural HBV cross-transmission. On the other hand, no
evidence has been obtained thus far for HBV transmission
from gibbon or chimpanzee to human. HBV is present at
levels as high as 161013 virions ml21 in the blood of HBV e
antigen (HBeAg)-positive patients but virus particles have
also been found in other body fluids, including saliva/
nasopharyngeal fluids, semen, cervical secretions and
The GenBank accession numbers of the sequences reported in this
paper are AF274495–96, AF274499, AF275378, AF477482–94,
AY077735–36 and AF529308–09.
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leukocytes (Alter et al., 1977; Davison et al., 1987). The
possibility of human HBV transmission through contact
with saliva from HBV chronic carriers has been obtained
both in humans as well as in gibbons (Bancroft et al., 1977;
MacQuarrie et al., 1974; Scott et al., 1980; Stornello, 1991).
In order to analyse possible routes of gibbon HBV
transmission, we determined the presence of HBV in
captive gibbons in Thailand by serological testing and HBV
DNA detection in chronic carriers. Sequencing and RFLP
analysis of the viruses permits molecular characterization of
gibbon HBV and possible routes of transmission between
gibbons, including vertical transmission. To investigate
horizontal transmission to humans, animal caretakers, some
of whom are HBV carriers, were analysed for the presence of
gibbon HBV. The unique deletion at the preS1 gene present
in gibbon HBV permits the accurate identification of a
zoonotic event.
METHODS
Study population. A total of 101 captive gibbons kept at the
Krabok Koo Wildlife Breeding Centre, Royal Forest Department in
Cha-Cheng-Sao, Thailand were included in the study. The gibbons
are housed in small monogamous families. Most of them were born
in the wild and all were examined in good health. The population
consists of 52 males and 49 females ranging from 1 to 21 years old
and of different species: Hylobates lar (white-handed gibbons,
n572), H. pileatus (pileated gibbons, n520), H. agilis (black-handed
gibbon, n52) and Nomascus concolar (Tonkin black-crested
gibbon, originally found in North Vietnam and central China,
n57). Two of the HBeAg-positive gibbons had their offspring aged
1 and 2 years.
Animal caretakers at the Krabok Koo Centre (n534) were screened for
the HBV surface antigen (HBsAg) during the prevaccination screening
programme.
Sample collection. Gibbon blood was obtained by venepuncture
during a brief period of anaesthesia by ketamine, part of the
routine health-care programme. Sera were separated from clotted
blood within 12 h by centrifuging at 1500 r.p.m. for 10 min and
kept at 270 ˚C. Human blood was separated using the same
procedure. Saliva samples were collected from 30 gibbons using the
OraSure collection system (OraSure Technologie) following the
manufacturer’s protocol. Samples were kept at 270 C˚ until further
testing.
HBV detection and liver function test analysis. All sera were
analysed for HBsAg, antibodies to HBsAg (anti-HBs) and anti-HBc
(antibodies to the HBV core antigen HBcAg) by enzyme immuno-
assay methodology (EIA) using a commercially available kit
(DiaSorin), according to the manufacturer’s instructions. HBeAg,
anti-HBc and anti-HBs antibodies of some samples were recon-
firmed by EIA kits obtained from Abbott Laboratories.
Gibbon HBV DNA was detected as described previously
(Theamboonlers et al., 1999). Briefly, DNA was extracted from
200 ml of serum with proteinase K in lysis buffer followed by phenol/
chloroform extraction and ethanol precipitation. The S gene was
amplified by nested PCR using two sets of primers: primer F1 (59-
GGAGCGGGAGCATTCGGGCCA-39, nt 3022–3042) and R6 (59-
GGCGAGAAAGTGAAAGCCTG-39, nt 1103–1084) were used for
first-round amplification and primers F2 (59-CATCCTCAGGCCATG-
CAGTGGA-39, nt 3192–3214) and R5 (59-AGCCCAAAAGACCC-
AGAAATTC-39, nt 1015–995) were used for second-round amplifica-
tion. The amplification reaction required 30 cycles comprising
initiation at 94 ˚C for 30 s, annealing at 55 ˚C for 30 s and extension
at 72 ˚C for 1 min, concluded by a final extension step at 72 ˚C for
10 min. The 1038 bp PCR product was detected by electrophoresis on
a 1.5 % agarose gel with ethidium bromide and visualized under UV
light.
The preS1/preS2 gene was detected using PCR primers P1 (59-
TCACCATATTCTTGGGAACAAGA-39, nt 2817–2839) and P2 (59-
TTCCTGAACTGGAGCCACCA-39, nt 80–61). The 478 bp PCR
product was used as template for RFLP analysis and DNA sequencing.
The X gene was amplified using primers Xo1 (59-CTCTGCCGAT-
CCATACTGC-39, nt 1256–1274) and PC1 (59-GGAAAGAAGTCAG-
AAGGC-39, nt 1974–1957). Amplified products were used for precore
mutant detection of gibbon HBV.
Sera of gibbon HBV carriers and HBsAg-negative animals were
analysed for alanine aminotransferase (ALT) at the Central Laboratory
of the Chulalongkorn University and Hospital (Bangkok, Thailand)
using an automated analyser (Hitachi 912). Data were expressed as
mean¡SD. The normal range of ALT is 0–38 U l21. Student’s t-test
was used to test statistical differences between groups.
Identification of gibbon HBV genotypes by RFLP. Two
restriction enzymes, AvaII and DpnII (New England Biolabs), were
used for digestion of the preS1/preS2 PCR products. The RFLP pat-
terns obtained were compared with the restriction endonuclease
analysis reference profiles for human HBV genotype classification as
described previously (Lindh et al., 1998). Samples with different
RFLP patterns were classified by direct sequencing.
The 720 bp PCR product of the X gene was digested with Sau3A I
(New England Biolabs) for precore promoter mutant gene detection
(nt 1762 and 1764), as reported previously (Takahashi et al., 1995).
Gibbon HBV sequencing and phylogenetic analysis. HBV
genes amplified by PCR were sequenced using the primer pairs P1
and P2, F2 and R5, and Xo1 and PC1 for the preS1/preS2, S and
core region, respectively. Sequencing reactions were performed using
the commercially available PRISM Ready Reaction Dye Deoxy
Terminator Cycle Sequencing kit (Applied Biosystems). The
sequence products were electrophoresed on a Perkin Elmer 310
sequencer (PE Biosystems). Each sample was sequenced in both
directions and nucleotide sequences were edited and assembled
using SEQMAN (LASERGENE program package, DNASTAR) and sub-
mitted to GenBank.
PreS1, S and core genes of two HBV carrier families were aligned using
BIOEDIT, the sequence alignment editor (version 5.0.9), while other
gibbon HBV strains were used as a control. For phylogenetic analysis, S
nucleotide sequences of 19 HBV carrier gibbons and two animal
caretakers were multiply aligned using the CLUSTAL X program. Genetic
distances were calculated using the Kimura two-parameter method
within DNADIST of PHYLIP, version 3.6 (J. Felsenstein, Department of
Genetics, University of Washington, USA) and the result was
illustrated graphically as a neighbour-joining tree. Bootstrap values
representing 1000 replicates (100 multiple data sets) were determined
using the SEQBOOT, DNADIST, NEIGHBOR and CONSENSE programs from
the PHYLIP package. The TREEVIEW program (version 1.5) was run for
unrooted phylogenetic construction.
To analyse the relationship between HBV isolates from animals in cage
C, the best phylogenetic tree of the complete S gene was generated with
the maximum-likelihood algorithms within the DNAML program using
1000 replicates of bootstrap values. The transition/transversion ratio
was 2?0.
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RESULTS
Seroprevalence of HBV in gibbons
To analyse the prevalence of HBV infection in Thai gibbons,
101 serum samples were tested for the presence of HBsAg
and antibodies to HBsAg and HBcAg. Serological testing
indicated that 38?6 % of the animals were positive for at least
one marker of HBV infection (Table 1). A total of 19
gibbons were chronic carriers, as defined by the presence of
HBV DNA and HBsAg, in the absence of antibodies to the S
protein. Interestingly, four of these animals were negative
for anti-HBc even when tested repeatedly using a different
EIA test. To test whether HBV infection was associated with
liver damage, ALT enzyme levels were determined in the sera
of 12 HBsAg-positive animals (Table 2) and 28 HBsAg-
negative animals (Table 2 and data not shown). Elevated
ALT levels were detected in HBV-infected gibbons
(68?8¡48?1 U l21) as compared to control animals
(33?0¡15?9 U l21, P,0?05). Approximately 20 % (20 of
101) of the animals recovered from the infection, as
evidenced by the presence of antibodies to S and core.
Serological markers of HBV infection in the chronic gibbons
are shown in Table 2, including the stage of HBV of their
families. Most of the HBV-infected gibbons were of the
species H. pileatus, kept in the cage C area (10 of 19). All
carriers’ partners were HBsAg-positive or had been infected
with HBV some time earlier. Two carrier families had
babies born in the Krabok Koo Centre (cages C15 and R6).
Tao C15, offspring of Ni and Saboo, was born in 1999 and
Table 1. Seroprevalence of gibbon HBV at the Krabok Koo
Centre
Stage of
infection HBsAg HBV DNA Anti-HBs Anti-HBc No.
No infection – – – – 62
Recovered – – + + 20
HBV carrier + + – + 15
HBV carrier + + – – 4
Table 2. HBV in serum and saliva of HBV carriers of gibbons and their couples
Serum Saliva
Cage Name Species Sex ALT (U l21) HBV DNA HBsAg Anti-S Anti-core HBV DNA HBsAg
C22 Daew H. pileatus F 48 + + – + + +
C21 Candy H. pileatus F 69 + + – – – +
C20 Jock H. pileatus M 46 + + – + – +
Koo H. pileatus F 36 – – + + – –
C16 NongChai H. pileatus M 50 + + – + – +
C15 Saboo H. pileatus M 207 + + – + – +
Ni H. pileatus F 70 + + – – – +
Tao* H. pileatus M ND + + – – ND ND
C14 Gomez H. pileatus M 93 + + – + – +
Chmi H. pileatus F 87 + + – + + +
C13 Saan H. pileatus M 46 + + – + + +
Kristine H. pileatus F 42 – – + + – –
C2 Pok H. lar M 39 + + – + + +
Mek H. lar F 21 – – + + – –
R4 Jacko H. lar M 50 + + – + – +
Ivana H. lar F 11 – – + + ND ND
R6 Jieb H. lar F 20 + + – + + +
Baby R6* H. lar M ND + + – – ND ND
Kingkong H. lar M ND – – + + ND ND
R27 Midnight H. lar M ND + + – + – +
L14 Nin H. lar M ND + + – + + +
Sang H. lar F ND – – + + ND ND
Baloo H. lar M ND – – + + ND ND
L10 Belle H. concolar F ND + + – + ND ND
Caesar H. concolar M ND + + – – ND ND
L9 Charlie H. concolar M ND + + – + ND ND
Ozzy H. concolar M ND – – + + ND ND
*Gibbons born recently at the Centre.
ND, Not determined.
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all family members were found to be positive for S
antigen and HBV DNA. Baby R6 was born in 2000 and
his mother, Jieb, is a HBV chronic carrier, while his father,
Kingkong, had natural immunity against HBV. Both mother
gibbons were found by EIA methodology to be HBeAg
positive.
Molecular characterization of gibbon HBV
HBV DNA isolated from 19 positive animals was used as
target for DNA sequencing and RFLP analysis. The absence
of the 33 bp after the preS1 start codon of gibbon HBV was
confirmed. Grouping of gibbon HBV was performed by
phylogenetic tree analysis; S phylogram analysis, including
human genotype A–G, orang-utan, chimpanzee and woolly
monkey, revealed the separate clustering of these gibbon
HBVs (Fig. 1). Most animals from the three different cages
cluster into the three separate groups. Animals in the closed
cage, such as area C, were infected with a closely related
strain of HBV since these viruses shared the root of the
phylogenetic tree. HBV from two chronically infected
mothers (Jieb and Ni) was more closely related to their
infants. The R6 family showed a higher internal edge value at
the node of the phylogram than the C15 family.
In order to analyse gibbon HBV transmission further,
comparison of HBV sequences from two pairs of mother
and baby gibbons was performed (GenBank accession nos
AF477490–91 and AF477493–94). Comparison of preS1
sequences, the most divergent part of the HBV genome,
indicated the close relation of these virus strains; Tao and
Baby R6 showed a difference of only 4 and 2 bases from their
mother, respectively, while 33–42 bases of the HBV
sequences from both couples differed as compared to a
nonrelated gibbon isolate (Fig. 2). Moreover, the preS1 gene
sequence isolated from Saboo (the C15 father gibbon),
showed a difference of 2 and 4 bases from dam and offspring
sequences, respectively. The HBV S gene from animals
in cage C showed a high percentage of sequence similarity,
indicating the close relation between these viruses; mother
and baby strains showed 99?5 % similarity (Table 3).
Nongchai (from the neighbouring cage C16) also showed
a high percentage of sequence similarity to Ni and Tao
(C15 cage). However, maximum-likelihood phylogenetic
analysis indicated the close relationship between Ni and
Tao strains (Fig. 3). Additionally, the partial core region of
both families showed 100 % identity among mothers
and babies (data not shown). Thus, taking into account
the relationships of these animals and the sequencing
results, vertical transmission may seem quite likely to have
occurred.
Precore promoter mutations at nt 1762 and 1764 were
detected by the Sau3A I restriction pattern (Fig. 4a). Four
carrier gibbons showed point mutations (G1-like pattern) in
this region, while one sample could not be typed (G4). All
mutated samples were positive for HBeAg testing.
Gibbon HBV transmission to humans
As shown in Table 2, HBsAg was found in all saliva samples
kept from carrier gibbons (n514), while HBV DNA was
detected in only six samples. Neither HBV DNA nor HBsAg
was detected in HBV seronegative (n57) and HBV
recovered gibbons (n59, data not shown).
A total of 34 animal caretakers of the Krabok Koo Centre
were screened during part of a prevaccination programme
and we found that 5?9 % (2 of 34) were positive for HBsAg
and HBV DNA. Subsequently, gibbon and human HBV
were identified by RFLP using AvaII/DpnII digestion of
preS1/preS2 PCR products, as indicated in Fig. 4(b, c),
respectively. Shown are representative digestion patterns
observed in samples G1–G4 and G6, gibbon virus strains
spreading in the Krabok Koo Centre; the G5 strain is similar
to G3. Two workers, H1 and H2, found to be HBs DNA
Fig. 1. Phylogram based on nucleotide sequences of the complete
S gene using the Kimura two-parameter matrix and neighbour-
joining method. Bootstrap values (1000 total) of ¢70 % are indi-
cated on the branches. Human and nonhuman primate HBV were
compared to gibbon and human HBV isolates identified in this
study. The GenBank accession numbers of reported sequences are
indicated in the phylogram. S gene sequences from gibbon HBV
presented in this tree are indicated by the name and cage of
animals, as shown in Table 2. All sequences were submitted to
GenBank: accession nos AF477482–94 and AF274495 (Candy
C21), AF274496 (Daew C22), AY077735 (Belle L10), AY077736
(Caesar L10), AF274499 (Charlie L9), AF275378 (Nin L14),
AF529308 (H1) and AF529309 (H2).
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positive might have been exposed to gibbon viruses. Patterns
of restriction enzyme digestion of gibbon HBV (G1–G6),
however, showed different profiles as compared to human
HBV (H1–H2). The 33 bp deletion in the preS1 region
caused the different RFLP patterns, which cannot be
grouped to any human virus genotype, including genotype
D viruses, which are reported to have a preS1 deletion in the
same region. These results were confirmed by sequencing
and phylogenetic analysis of the S gene (Fig. 1).
DISCUSSION
Wild gibbons (Hylobates species) can be found throughout
the tropical rainforests of South and Southeast Asia,
Fig. 2. Alignment of preS1 sequences from gibbon HBV. Sequences from two chronic carrier families and Nongchai (C16)
were aligned using the BIOEDIT program to analyse vertical transmission in gibbons. All sequences were compared to Belle
(L10) strain, as a control. Dots indicate identical nucleotide sequences, while slashes indicate insertion/deletion sequences.
GenBank accession numbers are given in the legend to Fig. 1.
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including Thailand, Laos, Cambodia, Indonesia and
Malaysia. The genus Hylobates is represented in these
areas by three species, the white-handed gibbons (H. lar),
the pileated gibbons (H. pileatus) and the black-handed
gibbons (H. agilis). They are at high risk of extinction due to
habitat loss and increased illegal pet trade. After categoriza-
tion as a conserved wild animal in Thailand, hundreds of
appropriated and abandoned gibbons have been handed
over to the authorities of the Thai government. An infec-
tious disease screening process was done to prevent possible
disease spreading that may interfere with the health and
reproduction of the wild gibbon population after reintro-
duction to the forest. Transmission of these viruses to humans,
which may constitute a public health risk, was also evaluated.
Serological analysis of HBV infection in the gibbons kept at
the Krabok Koo Centre showed that approximately 40 % of
the animals were infected with HBV; 19 animals were HBV
DNA-positive carriers and could be a source of virus spread
in the gibbon population. Similar figures have been reported
recently in captive gibbons housed in the Centre for Gibbon
Studies in California, USA, by Lanford et al. (2000). On the
other hand, Grethe et al. (2000) reported even higher
frequencies in animals housed at different zoos. Similar to
the first report on gibbon HBV (Mimms et al., 1993), four of
the chronically infected gibbons were negative for anti-HBc,
even when tested repeatedly with different EIA tests. The
specific immune response against core may be undetectable
due to the lack of specific anti-gibbon IgG reagents.
Precore promoter mutation AGGRTGA at nt 1762 and
1764, linked previously to a relatively moderate down-
regulation of the synthesis of HBeAg (Buckwold et al., 1996;
Moriyama et al., 1996) but also observed in the HBeAg-
positive stage (Takahashi et al., 1995), has been associated
with more severe liver damage (Lindh et al., 1999) and
increased responses to interferon (Kanai et al., 1996). In
gibbon HBV carriers, this mutation was detected in four
HBeAg-positive animals, including Pok C2, Midnight R27,
Nin L14 (all anti-core positive) and Caesar L10 (anti-core
negative). Unfortunately, core gene sequencing and ALT
status in these gibbons could not be analysed in this study
due to the limitation of samples.
Molecular characterization by RFLP and phylogenetic
analyses confirmed the separate clustering of gibbon HBV
compared to human and nonhuman primate HBV. The
three different clusters within the gibbon viruses observed
could relate to genomic variants as described by Grethe et al.
(2000). Interestingly, animals in the C and L cage areas
shared the same branches of each group, suggesting the
possibility of brother-and-sister relationships of these
animals or horizontal transmission by infectious viruses
in saliva during fights or feeding at an early age.
The recent finding that chimpanzees as well as orang-utans
can be infected with HBV in the wild makes any proposed
spread of HBV from the New World extremely unlikely
Table 3. Percentage sequence similarity of gibbon HBs gene isolated from family R6 and cage C animals
Candy Chmi Daew Gomez Jock Nongchai Saboo Tao Ni Jieb Baby R6
Candy 100 98.7 98.1 98.6 97.8 98.2 97.2 98.3 98.4 93.7 93.3
Chmi – 100 96.8 97.6 96.9 97.3 96.3 97.4 97.5 92.8 92.3
Daew – – 100 98.4 97.6 98.1 97.0 98.2 98.2 94.1 93.6
Gomez – – – 100 98.3 98.6 97.6 98.8 98.9 93.7 93.3
Jock – – – – 100 98.5 97.6 98.8 98.8 93.3 92.9
Nongchai – – – – – 100 98.1 99.2 99.3 93.7 93.3
Saboo – – – – – – 100 98.2 98.3 92.5 92.5
Tao – – – – – – – 100 99.5 93.8 93.4
Ni – – – – – – – – 100 94.1 93.6
Jieb – – – – – – – – – 100 99.5
Baby R6 – – – – – – – – – – 100
Fig. 3. Maximum-likelihood phylogenetic analysis of S gene
sequences of gibbon HBV isolated from animals in cage C.
The best tree was constructed using 1000 bootstrap values.
Accession numbers of all sequences are described in the
legend to Fig. 1.
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(Hu et al., 2000; MacDonald et al., 2000; Takahashi et al.,
2000; Warren et al., 1999). In contrast, all data support the
idea that these viruses are indigenous to the different
nonhuman primate populations. The geographical distribu-
tion of human genotype C viruses, the orang-utan HBV and
gibbon HBV, all found in Southeast Asia, could indicate that
spread through cross-species transmission in Southeast Asia
may have occurred (Simmonds, 2001). However, gibbon
and orang-utan HBV are more closely related to each other
than to the human genotypes. Thus, more sequence data on
different isolates are needed as well as possible evidence for
transmission of nonhuman primate HBV to humans.
HBV is transmitted by sexual contact and parental exposure,
although it is thought that mother-to-child prenatal
transmission is responsible for high rates endemically in
several regions of the world; 25–50 % of the HBV chronic
carriers result through vertical transmission or horizontal
transmission by nosocomial exposure in early childhood
(Mast et al., 1999; Mahoney, 1999; Wang & Zhu, 2000).
In gibbons, vertical transmission was supported by 99.5 %
identity of the S gene of HBV isolated from mother and baby
gibbons. Hence, base sequence changing may have occurred
through mutations in time; for example, Baby R6, younger
than Tao at the date of blood sampling, showed higher
sequence similarity of the preS1 region (Fig. 2).
Unexpectedly, HBV isolated from Nongchai (C16 cage)
showed a high percentage of sequence similarity to Ni and
Tao (cage C15), possibly due to horizontal transmission.
However, HBsAg isolated from Ni and Tao were more
closely related, as determined by maximum-likelihood
phylogram analysis. Noticeably, all animals that share
cages with gibbon carriers were infected with HBV and
anti-core antibodies were detected (Table 2). These data
suggest that sexual contact or horizontal HBV transmission
of family members could be a source of virus spread in this
gibbon population.
Similar to observations made in human HBV
(Noppornpanth et al., 2000), HBsAg could be detected in
the saliva of all HBV carriers. Until now, few cases have been
reported on HBV infection from saliva by a human bite
(MacQuarrie et al., 1974; Stornello, 1991) but the high
prevalence of HBV among dentist personnel and family
members suggests that HBV might spread by saliva
(Heathcote et al., 1974). However, no report of HBV
transmission from captive animals to humans currently
exists. In the present study, HBV DNA was detected in the
saliva of six gibbons, representing circulating HBV
infectious particles in body fluids (Ljunggren et al., 1993).
HBV-positive human saliva administered intradermally, but
not orally, to gibbons caused HBV transmission (Scott et al.,
1980). Thus, HBV DNA detected in gibbon saliva may
indicate a potential risk for horizontal transmission, espe-
cially if the animals are injured after fighting or through
accidental injury of animal caretakers. Two workers of the
Kabok Koo Centre were found to be positive for HBsAg and
HBV DNA, which corresponds to seroprevalence of HBV in
the general adult Thai population (Tandon & Tandon, 1997).
RFLP and phylogenetic analyses of the S gene from both
isolates indicated that they were infected by human HBV.
The high prevalence of HBV infection in captive gibbons of
the Krabok Koo Centre shows that HBV is an important
infectious agent in captive gibbons. Since chronic carrier
gibbons are the main source of HBV in the Centre,
separating them and vaccination of newborn babies should
be done to reduce the number of infected animals. Although
transmission of HBV between nonhuman primates and
humans, similar to zoonotic human immunodeficiency
virus transmission (Hahn et al., 2000), could not be
confirmed, these studies could provide more insight in
the molecular evolution and transmission routes of HBV
and facilitate our understanding of the origin of HBV and its
pathogenesis.
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